Del Mar, California
United States
34
2025-01-02
34
2025-07-01
These are the the leading inventors for applications assigned to BioMadison, Inc.:
BioMadison, Inc. based in Del Mar, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Peptides for Characterization of Botulinum Neurotoxins
#2 | 2024-04-11 ✅ Patent 12,209,269 granted on 2025-01-28Cell for use in enzyme assays
#3 | 2022-11-24 ✅ Patent 12,560,606 granted on 2026-02-24Compositions for Determining Vaccine Potency
#4 | 2022-08-18 ✅ Patent 12,422,428 granted on 2025-09-23Compositions and Methods for Cell-Based Assays
#5 | 2022-06-23 ✅ Patent 12,287,323 granted on 2025-04-29Reporting construct with synaptobrevin based moiety
#6 | 2021-09-02 ✅ Patent 11,661,442 granted on 2023-05-30Vesicles for characterization of botulinum neurotoxins
#7 | 2021-02-04 ✅ Patent 11,685,945 granted on 2023-06-27Enzyme assay with duplicate fluorophores
#8 | 2021-01-14 ✅ Patent 11,320,420 granted on 2022-05-03Compositions and methods for improving sensitivity in cell based assays
#9 | 2020-11-19 ✅ Patent 11,333,664 granted on 2022-05-17Methods for improving uptake of neurotoxin
#10 | 2020-09-17 ✅ Patent 11,578,099 granted on 2023-02-14Compositions and methods for removal of detergents from aqueous solutions
#11 | 2020-04-09 ✅ Patent 10,975,125 granted on 2021-04-13Reporting constructs for characterization of neurotoxins
#12 | 2019-12-19 ✅ Patent 11,357,838 granted on 2022-06-14Botulinum neurotoxins with modified light chain specificity and methods for producing same
#13 | 2019-11-07 ✅ Patent 11,435,351 granted on 2022-09-06Methods for determining vaccine potency
#14 | 2019-10-31 ✅ Patent 10,908,146 granted on 2021-02-02Compositions and methods for improving sensitivity in cell based assays
#15 | 2019-05-23 ✅ Patent 10,508,135 granted on 2019-12-17Non-FRET cell based assay
#16 | 2019-05-16 ✅ Patent 10,768,178 granted on 2020-09-08Compositions and methods for improved cell-based botulinum neurotoxin assays
#17 | 2018-09-06 ✅ Patent 10,526,637 granted on 2020-01-07Compositions and methods for improved neurotoxin assays
#18 | 2018-03-15 ✅ Patent 12,019,066 granted on 2024-06-25Assay with synaptobrevin based moiety
#19 | 2018-03-15 ✅ Patent 11,325,954 granted on 2022-05-10Compositions and methods for stability testing of botulinum toxin
#20 | 2017-10-05 ✅ Patent 9,988,666 granted on 2018-06-05Resonance energy transfer assay with cleavage sequence and spacer
#21 | 2017-04-06 ✅ Patent 10,191,051 granted on 2019-01-29Compositions and methods for improved cell-based botulinum neurotoxin assays
#22 | 2016-08-11 ✅ Patent 10,100,094 granted on 2018-10-16Fusion proteins, cells, and kits for characterizing Botulinum toxin
#23 | 2016-08-04 ✅ Patent 10,317,394 granted on 2019-06-11Sensitized cultured cells for botulinum toxin characterization
#24 | 2016-06-23 ✅ Patent 9,677,113 granted on 2017-06-13Resonance energy transfer assay with cleavage sequence and spacer
#25 | 2016-06-02 ✅ Patent 10,441,640 granted on 2019-10-15Botulinum neurotoxins with modified light chain specificity and methods for producing same
#26 | 2016-03-10 ✅ Patent 10,246,492 granted on 2019-04-02Botulinum assay with synaptobrevin substrate moiety
#27 | 2015-06-25 ✅ Patent 9,249,451 granted on 2016-02-02Resonance energy transfer assay with cleavage sequence and spacer
#28 | 2015-06-11 ✅ Patent 9,526,345 granted on 2016-12-27Botulinum toxin assay with improved sensitivity
#29 | 2014-01-23 ✅ Patent 9,303,285 granted on 2016-04-05Methods and compounds for increasing sensitivity of botulinum assays
#30 | 2013-10-29 ✅ Patent 8,569,346 granted on 2013-10-29Thiazoline ring compounds as botulinum antagonists
#31 | 2013-04-18 ✅ Patent 8,969,016 granted on 2015-03-03Resonance energy transfer assay with cleavage sequence and spacer
#32 | 2012-12-20 ✅ Patent 9,453,254 granted on 2016-09-27Resonance energy transfer assay with synaptobrevin substrate moiety
#33 | 2012-12-06 ✅ Patent 9,274,121 granted on 2016-03-01Non-FRET botulinum assay
#34 | 2011-02-10 ✅ Patent 9,303,284 granted on 2016-04-05Resonance energy transfer assay with cleavage sequence and spacer
Also check out BIOMADISON, INC.'s (Del Mar, United States) applicant profile with 29 patent applications submitted.
357581 ⎘